Experiments in mice infected with the SARS-CoV-2 virus revealed that the immune cell class in question, called nerve and ...

Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer.  This procedure focuses on a ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Biotechnology company Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion technologies. The patent covers mucosal-associated ...

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of ...

"The absence of these NAM immune cells leads to an exaggerated inflammatory ... rely on type 1 interferon signaling for their expansion and normal functioning during SARS-CoV-2 infection," said ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.

Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients.

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...